827043-71-0

Upstream product

• 827043-67-4 (1R,2R,3R,4R,5S)-3,4-di-O-benzoyl-5-(benzyloxymethyl)-1,2-O-ethylpropylidene-4-cyclohexene-1,2,3,4,5-pentol 
• 827043-68-5 (1R,2R,3R,4R)-3,4-di-O-benzoyl-5-(benzyloxymethyl)-1,2-O-ethylpropylidene-4-cyclohexene-1,2,3,4-tetraol 
• 827043-69-6 (1R,2R,3R,4R)-3,4-di-O-benzoyl-5-(benzyloxymethyl)-5-cyclohexene-1,2,3,4-tetraol 
• 827043-66-3 (1R,2R,3S,4R,5R)-3-O-benzoyl-5-(benzyloxymethyl)-1,2-O-ethylpropylidene-4-cyclohexene-1,2,3,4,5-pentol 
• 827043-65-2 (1R,2R,3S)-3-O-benzoyl-5-(benzyloxymethyl)-1,2-O-ethylpropylidene-4-cyclohexene-1,2,3-triol 
• 374687-82-8 (1R,2S,3S)-1,2-O-ethylpropylidene-5-(hydroxymethyl)-4-cyclohexene-1,2,3-triol 
• 827043-70-9 (1S,2S,3S,4R)-3,4-di-O-benzoyl-5-(benzyloxymethyl)-1-chloro-2-O-(N,N-dimethylcarbamoyl)-5-cyclohexene-2,3,4-triol 

Relevant academic research and scientific papers

Facile, efficient, and enantiospecific syntheses of 1,1′-N-linked pseudodisaccharides as a new class of glycosidase inhibitors

This article describes an efficient synthesis of a potent trehalase inhibitor, 1,1′-N-linked pseudodisaccharide 1 (consisting of two valienamines), in 14 steps with an overall yield of 12% and a first synthesis of 2 (consisting of two 2-epi-valienamines)